BIOEQUIVALENCE;
CONDITIONING;
COST CONTROL;
DRUG INDUSTRY;
DRUG QUALITY;
DRUG SUBSTITUTION;
ECONOMIC ASPECT;
LETTER;
PRESCRIPTION;
DRUG THERAPY;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
DRUG PRESCRIPTIONS;
DRUG THERAPY;
DRUGS, GENERIC;
HUMANS;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
EID: 67650233377PISSN: 11107243EISSN: 11107251Source Type: Journal DOI: 10.1155/2009/801984Document Type: Letter
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: A systematic review and meta-analysis
Kesselheim A. S., Misono A. S., Lee J. L., Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis Journal of the American Medical Association 2008 300 21 2514 2526
Symptom relapse following switch from Celexa to generic citalopram: An anxiety disorders case series
Van Ameringen M., Mancini C., Patterson B., Bennett M., Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series Journal of Psychopharmacology 2007 21 5 472 476
Mechanisms of placebo and placebo-related effects across diseases and treatments
Benedetti F., Mechanisms of placebo and placebo-related effects across diseases and treatments Annual Review of Pharmacology and Toxicology 2008 48 33 60
The effect of price, brand name, and store name on buyers perceptions of product quality: An integrative review
Rao A. R., Monroe K. B., The effect of price, brand name, and store name on buyers perceptions of product quality: an integrative review Journal of Marketing Research 1989 26 3 351 357
Commercial features of placebo and therapeutic efficacy
Waber R. L., Shiv B., Carmon Z., Ariely D., Commercial features of placebo and therapeutic efficacy Journal of the American Medical Association 2008 299 9 1016 1017
